Debra Richardson to Cystadenocarcinoma, Serous
This is a "connection" page, showing publications Debra Richardson has written about Cystadenocarcinoma, Serous.
Connection Strength
0.164
-
Is there a high-risk subgroup of stage I epithelial ovarian cancer that is most likely to benefit from 6 versus 3 cycles of adjuvant chemotherapy? Int J Gynecol Cancer. 2010 Oct; 20(7):1125-31.
Score: 0.085
-
Outpatient platinum-taxane intraperitoneal chemotherapy regimen for ovarian cancer. Int J Gynecol Cancer. 2009 Oct; 19(7):1195-8.
Score: 0.079